03Oct 2022
Testing for association between exonic glucagon‐like peptide 1 receptor (GLP‐1R) mutation with physical and brain health traits in UK Biobank

Testing for association between exonic glucagon‐like peptide 1 receptor (GLP‐1R) mutation with physical and brain health traits in UK Biobank

A low‐frequency exonic single nucleotide variation (SNV) in the GLP‐1R gene, rs10305492, has been associated with differences in cardiometabolic health. There is, however, a lack of data regarding rs10305492 and brain health metrics; this study aimed to test for potential associations. We tested for association between rs10305492 A allele presence vs cognitive, brain imaging and dementia‐related outcomes based on self‐report and incident cases from hospital episode statistics in UK Biobank (n range = 47,920 to 395,475). Despite significant associations with better physical health traits, there were generally no rs10305492‐A associations with scores on cognitive tests, structural brain phenotype metrics or all‐cause dementia, Alzheimer's disease or vascular dementia. These findings support clinical trial data in providing orthogonal, genetics‐based evidence suggesting efficacy for GLP‐1R agonists on physical health.

  • #neurology

Like

Save

Share